The Spine Journal
Volume 10, Issue 3 , Pages 238-240, March 2010

North American Spine Society:

Newly released vertebroplasty randomized controlled trials: a tale of two trials

  • Christopher M. Bono, MD

      Affiliations

    • Department of Orthopedic Surgery, Brigham & Women's Hospital, 75 Francis Street, Boston, MA 02115-6110, USA
    • Corresponding Author InformationCorresponding author. Department of Orthopedic Surgery, Brigham & Women's Hospital, 75 Francis Street, Boston, MA 02115-6110, USA. Tel.: (1) 617-732-7238; fax: (1) 617-732-6937.
    • ,
  • Michael Heggeness, MD, PhD

      Affiliations

    • Orthopedic Department, Baylor College of Medicine, 1709 Dryden Road, Suite 1230, Houston, TX 77030-2400, USA
    • ,
  • Charles Mick, MD

      Affiliations

    • Pioneer Spine & Sports, 766 North King Street, Northampton, MA 01060-1142, USA
    • ,
  • Daniel Resnick, MD

      Affiliations

    • Department of Neurosurgery, University of Wisconsin Medical School, 600 Highland, K4/834 Clinical Science Center, Madison, WI 53792-0001, USA
    • ,
  • William C. Watters III, MD

      Affiliations

    • Bone & Joint Clinic of Houston, 6624 Fannin Street, Suite 2600, Houston, TX 77030-2338, USA

Received 22 September 2009; accepted 24 September 2009. published online 12 October 2009.

This commentary is a product of the North American Spine Society (NASS). It was approved by the NASS Board of Directors and accepted for publication outside The Spine Journal's peer review process.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 FDA device/drug status: not applicable

 Author disclosures: CMB (royalties, Life Spine [Level B]; consulting, Depuy Spine [Level B], Medtronic Sofamor Danek [Level B]; speaking/teaching arrangements, Depuy Spine [Level C], Stryker Spine [Level B]; board of directors, North American Spine Society; other office, Applied Spine [Level B, Adverse Events Panel]; research support, Archus Orthopedics [Level B], Synthes Spine [Level D]; grants, Stryker Spine [Level D]; fellowship support, Depuy Spine [Level E]); MH (royalties, Relievant Medsystems [Level C]; stock ownership, Relievant Medsystems [Level D]; consulting, Relievant Medsystems [Level D, 2008; none, 2009]; board of directors, North American Spine Society; research support, investigator salary, Department of Defense [Level E]; grants, Department of Defense [Level I, not directly related to the spine]); CM (board of directors, North American Spine Society; relationships outside the 1-year requirement, DePuy [Level A], Synthes [Level A], St. Francis Medical [Level A]; other, NASS Board, Coding Committee, Performance Measure Committee, Advocacy Council Chair, Annual Meeting, NASS RUC Rep); DR (board of directors, North American Spine Society; relationships outside the 1-year requirement, Medtronic [consultant 2003–2006, minimal-less than Level B over entire duration]); WCW (consulting, Stryker [Level C]; board of directors, North American Spine Society; scientific advisory board, Intrinsic Therapeutics [nonfinancial, stock options (no current value)]; others, Blackstone Medical Inc. [financial, Clinical Events Committee for clinical trial]).

PII: S1529-9430(09)00984-X

doi:10.1016/j.spinee.2009.09.007

The Spine Journal
Volume 10, Issue 3 , Pages 238-240, March 2010

Article Tools